Cell & Gene Therapy Testing
RAPID RESULTS YOU CAN TRUST
Cutting-edge cellular therapy products demand state-of-the-art quality control. Discover our fully-automated, ultra-sensitive testing solutions with very short TTR .
Discover More Resources
ON-DEMAND: BACT/ALERT® 3D: FROM ALTERNATIVE TO ROUTINE FOR TESTING CELL AND GENE THERAPY PRODUCTS
Listen to Lori Daane, Sr. Director of Scientific Affairs at bioMérieux, discuss rapid sterility testing within the cell and gene therapy landscape. She discusses the evolving regulations and why the BACT/ALERT® has continued to be the go-to instrument of choice for testing these products for microbial contamination.
CUTIBACTERIUM ACNES GRAM POSITIVE BACTERIA CAUSING INFECTION
Cutibacterium acnes (C. acnes) is a Gram positive bacteria that prefers anaerobic (without air) growth conditions1. Cutibacterium acnes can be found on the skin of virtually every human, and it is one of the bacteria that can cause acne. Acne is one of the most common skin diseases, affecting more than 45 million individuals in the United States.
RAPID STERILITY TESTING OF GENE AND CELL THERAPY PRODUCTS
Gene and cell therapy products, also known as advanced therapy medicinal products (ATMP), present unique challenges for Quality Control release testing due to their very short shelf life, fast medical need for dosing patients, and limited availability of product for sterility testing. As such, meeting the requirements for existing compendial sterility test methods is often difficult, if not impossible, to achieve.